Love Research is a joint campaign between Cambridge University Hospitals NHS Foundation Trust, Royal Papworth Hospital NHS Foundation Trust, and Cambridgeshire and Peterborough NHS Foundation Trust, designed to raise awareness of our world-leading healthcare research and encourage staff-patient conversations about participating in research.
Research is the bedrock upon which our future health depends. Only by conducting high-quality research can we discover new and better ways of preventing, diagnosing, treating and curing illness and disease.
Cambridgeshire is a thriving life science ecosystem of world-class hospitals, research institutes, laboratories, academia, and clinical teams with a shared passion for innovation and improving healthcare.
Survey
Research - your views
Please spare up to five minutes to complete our patient survey. By giving us your feedback, you will be helping to shape our plans moving forwards.
Complete survey (opens in a new tab)
Case studies
Natalie Tanzarella - Clinical Research Practitioner
The DIAMONDS study looks into whether a tailored education package could help people with severe mental illness to better manage their type 2 diabetes.
Research at CPFT (opens in a new tab)CPFTWithout volunteers taking part in research, there wouldn’t be any new treatments. Who knows what research might help you as an individual in the future?
Natalie Tanzarella
Information
Why research matters
CUH brings its daily experience of patient-led care together with ground-breaking research programmes to provide cutting edge medical advancements to patients.
Find out more (opens in a new tab)
Case studies
Jacqui Galloway - Specialist research nurse
Lead Clinical Nurse Specialist Jacqui Galloway is one of CUH’s few specialist research nurses. She describes working in research as a demanding – but rewarding – job.
Read Jacqui's story (opens in a new tab)ResearchWe are ambassadors; we will promote a career in research to everybody. And I will encourage my patients to join trials for as long as I am a nurse.
Jacqui Galloway
